Department of Pharmacology: David James Lecture 2026, Prof Lotte Bjerre Knudsen

Add to your list(s) Download to your calendar using vCal

• Professor Lotte Bjerre Knudsen, Head of IDEA and Chief Scientific Advisor at Novo Nordisk
• Friday 16 January 2026, 13:00-14:00
• Department of Biochemistry, Jean Thomas Lecture Theatre.

If you have a question about this talk, please contact comms.

Department of Pharmacology: David James Lecture 2026

Speaker: Professor Lotte Bjerre Knudsen, Head of IDEA and Chief Scientific Advisor at Novo Nordisk

Title: GLP -1: the medicines, the biology, and the learnings

Date and Time: Friday 16 January, 13:00. Reception to follow at 14:00

Location: Department of Biochemistry, Jean Thomas Lecture Theatre

In person only. Registration required: https://www.eventbrite.com/e/david-james-lecture-2026-professor-lotte-bjerre-knudsen-tickets-1970260479131

Biography: Lotte Bjerre Knudsen is a Danish national, born in 1964 in a small town near Copenhagen. Lotte holds a degree in biotechnology from the Technical University of Denmark, and a Doctoral Degree in Scientific Medicine from the University of Copenhagen, and she is an Adjunct Professor of Translational Medicine for Aahus University. Lotte has an H-index of 63, is an inventor on numerous patents, and is most prominently a recipient of the Paul Langerhans Award, the Science Mani Bhaumik Breakthrough of the Year Award, the Lasker-DeBakey Clinical Research Award and the Breakthrough Prize of Life Sciences.

Lotte Bjerre Knudsen is the Chief Scientific Advisor for R&D at Novo Nordisk. She heads up the team IDEA (Innovation & Data Experimentation Advancement) that focuses entirely on human data driven insights to inform drug discovery. Lotte has held her current role since 2022, after spending 2021 in Oxford. She is a long-time employee of Novo Nordisk, since 1989. Lotte is a co-inventor of liraglutide and has led all biology research programs for liraglutide and semaglutide from diabetes to obesity, cardiovascular, liver, kidney and Alzheimer’s Disease. She has been part of representing Novo Nordisk in five FDA Advisory committees

Lotte has received numerous awards. Most recently, she was a recipient of the 2025 Breakthrough Prize in Life Sciences, the Paul Langerhans Award from the German Diabetes Association, the STAT Biomedical Innovation Award, and a co-recipient of the American Association for the Advancement of Science Mani Bhaumik Breakthrough of the Year Award.

The David James Lectures are the Department of Pharmacology’s flagship lecture series. Named after Dr David James, a former Departmental Administrator who left behind a legacy to the Department to provide scholarships to gifted postgraduates, this series aims to draw superstar research speakers to Cambridge, promoting collaboration and sparking inspiration. A list of previous speakers can be found here: https://www.phar.cam.ac.uk/david-james-annual-seminar-series.

This talk is part of the Department of Pharmacology Seminar Series series.

This talk is included in these lists:

• Biology
• Cambridge Neuroscience Seminars
• Cambridge talks
• Chris Davis' list
• Department of Biochemistry, Jean Thomas Lecture Theatre
• Department of Pharmacology Seminar Series
• Featured lists
• Life Science
• Life Sciences
• Neuroscience
• Neuroscience Seminars
• Neuroscience Seminars
• Stem Cells & Regenerative Medicine
• dh539
• dh539

Note that ex-directory lists are not shown.